Show simple item record

dc.contributor.authorBoughton, Charlotte K
dc.contributor.authorHartnell, Sara
dc.contributor.authorAllen, Janet M
dc.contributor.authorFuchs, Julia
dc.contributor.authorHovorka, Roman
dc.date.accessioned2022-01-10T12:45:07Z
dc.date.available2022-01-10T12:45:07Z
dc.date.issued2022-01
dc.identifier.issn1932-2968
dc.identifier.other10.1177_1932296820955168
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/332478
dc.description.abstractHybrid closed-loop therapy is an emerging technology transforming the management of type 1 diabetes (T1D). Research studies demonstrate glycemic and quality of life benefits of hybrid closed-loop therapy for people with T1D. Translating these outcomes into standard clinical practice is critical for reimbursement and improving access to this technology.High-quality training is essential for achieving optimal outcomes with hybrid closed-loop therapy. Basic diabetes skills and tasks are as important, or even more important, with closed-loop therapy than with standard insulin therapy and need to be reiterated. Establishing expectations of hybrid closed-loop therapy clearly at the outset promotes long-term usage and optimal outcomes.We share key aspects of training and support for users of commercially available hybrid closed-loop systems and consider who may benefit from this technology.
dc.languageen
dc.publisherSAGE Publications
dc.subjectCommentaries
dc.subjectartificial pancreas
dc.subjecthybrid closed-loop
dc.subjecttraining
dc.subjecttype 1 diabetes
dc.titleTraining and Support for Hybrid Closed-Loop Therapy.
dc.typeArticle
dc.date.updated2022-01-10T12:45:06Z
prism.endingPage223
prism.issueIdentifier1
prism.publicationNameJ Diabetes Sci Technol
prism.startingPage218
prism.volume16
dc.identifier.doi10.17863/CAM.79928
dcterms.dateAccepted2020-08-05
rioxxterms.versionofrecord10.1177/1932296820955168
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/
rioxxterms.licenseref.startdate2020-09-11
dc.contributor.orcidBoughton, Charlotte K [0000-0003-3272-9544]
dc.contributor.orcidFuchs, Julia [0000-0002-4497-0979]
dc.identifier.eissn1932-2968
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (EME 14/23/09)
pubs.funder-project-idWellcome Trust (100574/B/12/Z)
pubs.funder-project-idHelmsley Charitable Trust (#2016PG-T1D046)
pubs.funder-project-idCambridge University Hospitals NHS Foundation Trust (CUH) (146281)
pubs.funder-project-idWellcome Trust (100574/Z/12/Z)
cam.issuedOnline2020-09-11
rioxxterms.freetoread.startdate2020-09-11
rioxxterms.freetoread.startdate2020-09-11


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record